Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2012 Aug;5(8):837–848. doi: 10.1016/j.jcmg.2012.06.003

Figure 4. Hazards Ratios and 95% Confidence Interval for longitudinal studies using Echocardiography to estimate LVM or LVMi as predictor of clinical outcomes.

Figure 4

composite 1 - fatal and nonfatal cardiovascular events, including sudden death and other cardiovascular deaths, myocardial infarction, stroke, heart failure requiring hospitalization, renal failure requiring dialysis, documented angina, transient ischemic attack, or peripheral occlusive arterial disease verified by angiography; Composite 2 - CV death, Ischemic heart disease, CHF, End-stage renal disease, peripheral arterial disease, and stroke; Composite 2 - coronary heart disease, congestive heart failure, stroke or transient ischemic attack and intermittent claudication; Composite 4 - new-onset coronary artery disease, stroke, transient cerebral ischemic attack, symptomatic aortoiliac occlusive disease verified at angiography, thrombotic occlusion of a retinal artery documented at fluoroangiography, progressive heart failure requiring hospitalization, and renal failure requiring dialysis; composite 5 - fatal and nonfatal MI, sudden cardiac death, fatal and nonfatal stroke, other cardiovascular deaths, all-cause death, severe heart failure requiring hospitalization and severe renal failure requiring dialysis; TIA - Transient ischemic attack; Composite 6 - end point of death from cardiovascular causes, reinfarction, heart failure, stroke, or resuscitation after cardiac arrest